Brain Computer Interface monitors brain activity, extract information from it, and translate those data into outputs that replace, repair, augment, supplement, or improve human activities.
Brain Computer Interface (BCI) |
A Brain Computer Interface (BCI) is a device that measures central
nervous system (CNS) activity and converts it into artificial output that
replaces, restores, enhances, supplements, or improves natural CNS output,
thereby altering the CNS's ongoing interactions with its external or internal
environment.
Brain
Computer Interface (BCI) may be used to replace lost
functions like speech and movement. They may help you regain control of your
body by activating neurons or muscles that move your hand. BCIs have also been
used to enhance functions, such as training users to improve the function of
damaged pathways that are essential for grasping. BCIs can also improve
function, such as alerting a drowsy driver to get out of the car. Finally, a
BCI might act as a complement to the body's natural outputs, such as a third
hand.
BCIs utilise
a variety of approaches to assess brain activity. Electrodes inserted
invasively within or on the surface of the cortex, or noninvasively on the
surface of the scalp [electroencephalography (EEG)] have been utilised in the
majority of BCIs. Some BCIs are based on noninvasive metabolic activity
measurements, such as functional magnetic resonance imaging (fMRI).
According to
Coherent Market Insights, The global Brain
Computer Interface (BCI) market is estimated to be valued at
US$ 773.0 million in 2021 and is expected to exhibit a CAGR of 11.4% over the
forecast period (2021-2028). Market companies are focused on different growth
tactics such as investments and financing to accelerate research in the field
of brain computer interface, which is projected to increase market growth
during the forecast period.
Coronavirus's Impact on the
Brain-Computer Interface Market (Covid-19) Pandemic
The majority
of nations have imposed a financial burden on the private healthcare industry
as a result of the shutdown. Additional labour, equipment, consumables, and
other resources are needed to guarantee hospital safety and to treat patients
with various conditions, which is a challenge for healthcare practitioners.
Furthermore,
the coronavirus pandemic has impeded the development, manufacture, and supply
of medications and other healthcare items, as well as impacted the expansion of
many healthcare firms throughout the world.
However, the
use of healthcare IT solutions across the ecosystem, including drug research,
drug development, diagnostics, data management, marketing, and patient
interaction, has seen a paradigm change. Companies such as Contract research
organisations (CROs), insurers, diagnostics, and research institutes are
rapidly adopting artificial intelligence, electronic health record (EHR),
revenue cycle management, reimbursement data management, and clinical data
management solutions for remote data monitoring.
Recent analysis on Brain Interface
Market- https://bit.ly/38fLO2O
Comments
Post a Comment